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ABSTRACT
Homing endonucleases are highly specific enzy-
mes, capable of recognizing and cleaving unique
DNA sequences in complex genomes. Since such
DNA cleavage events can result in targeted allele-
inactivation and/or allele-replacement in vivo, the
ability to engineer homing endonucleases matched
to specific DNA sequences of interest would enable
powerful and precise genome manipulations. We
have taken a step-wise genetic approach in analyz-
ing individual homing endonuclease I-CreI protein/
DNA contacts, and describe here novel interactions
at four distinct target site positions. Crystal struc-
tures of two mutant endonucleases reveal the
molecular interactions responsible for their altered
DNA target specificities. We also combine novel
contacts to create an endonuclease with the pre-
dicted target specificity. These studies provide
important insights into engineering homing endo-
nucleases with novel target specificities, as well as
into the evolution of DNA recognition by this
fascinating family of proteins.
INTRODUCTION
Homing endonucleases are enzymes that recognize and
cleave DNA target sequences of sufﬁcient length (14–
40 bp) to be unique in complex genomes (1,2). In nature
they are often encoded by genes imbedded in introns or
inteins, and function to promote lateral transfer of these
intervening sequences. The lateral transmission mechanism
involves homing endonuclease mediated cleavage of a
target allele, followed by homology-based DNA double-
strand break repair (2–4).
Homing endonucleases have been introduced into
bacterial, plant, insect and mammalian cells, where they
have been shown to recognize and cleave their speciﬁc targets
(5–10). Such homing endonuclease induced DNA double-
strand breaks may be lethal, mutagenic or repaired by
homologous recombination. The ability to engineer homing
endonucleases capable of cleaving speciﬁc DNA sequences
of interest could enable new allele-speciﬁc replacement and
inactivation strategies in a wide variety of organisms.
I-CreI has become the most extensively engineered homing
endonuclease. Structural studies have deﬁned the key
protein/DNA interactions between the homodimeric enzyme
and its largely palindromic DNA target site (Figure 1)
(11,12). By systematically altering single protein/DNA
contacts, we have previously described novel endonucleases
that target mutant sites altered at three different positions:
±6, 10 and 11 (Figure 1) (13,14). Here, we employ saturation
mutagenesis to examine contacts at three other positions: ±4,
5 and 7 (Figure 1). Two of these positions (±4 and 5) were
previously examined in a high-throughput assay in which
I-CreI derivatives simultaneously altered at three residues
were selected from a non-saturating combinatorial library
(15). We describe here a substitution at residue 44, not
identiﬁed among the hundreds of I-CreI derivatives isolated
in the high-throughput assay (15), which imparts speciﬁc
recognition of a mutant site altered at position ±4. We also
describe a speciﬁcity broadening substitution at residue 28,
and show that the interaction between I-CreI residue 68 and
target position ±5 is completely recalcitrant to individual
speciﬁcity-shifting mutations. We demonstrate enhanced
recognition of ±6 mutant sites (14) by altering a residue
that normally interacts with DNA via a water-mediated
contact, and employ a non-saturation mutagenesis screen to
identify I-CreI derivatives with multiple substitutions that
target sites altered at position ±9. In all, we report on the
screening of over 400 endonuclease/target site combinations
(Table 1). Finally, we show that it is possible to mix and
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positions.
MATERIALS AND METHODS
Bacterial strains and media
In vivo assays were performed in the Escherichia coli K-12
strain MC1000 [araD139 D(ara,leu)7697 D(lac)X74 galE
galK thi rpsL] harboring F0—lac episomes with I-CreI tar-
get sites situated in place of lacO sequences as described
previously (13). Standard growth media were used (16).
Where required, media were supplemented with ampicillin
(200 mg/ml), chloramphenicol (30 mg/ml), tetracycline
(10 mg/ml), X-Gal (40 mg/ml) and arabinose (0.2%).
Plasmids
I-CreI derivatives were constructed in plasmid pA-E using
cassette mutagenesis as described previously (13). Mutations
were subcloned to a C-Terminal His-tagged version of the
arabinose inducible plasmid pB-E to purify protein for
in vitro cleavage assays (14). All mutants were sequence
veriﬁed. I-CreI homing site containing plasmids pKS155 (5)
and pBR-O-Xho (13) have been described.
Competitive cleavage assays
His-tagged versions of endonucleases were puriﬁed using
nickel-afﬁnity chromatography, following a 2 h arabinose
induction of mid-exponential cells (14). The abilities of mut-
ant I-CreI homing sites (present on pBR-O-Xho) to serve as
substrates for puriﬁed I-CreI were determined as described
previously (13,14). Assays were performed on 100 ng of
each linearized plasmid (pBR-O-Xho for mutant target sites
and pKS155 for wild-type) in 10 ml of 20 mM Tris (pH
9.0), 10 mM MgCl2, 1 mM DTT and 50 mg/ml BSA. Minimal
enzyme amounts sufﬁcient to achieve complete digestion of
each substrate were determined empirically (see Figure 3,
1X samples), and used to initiate a series of 2-fold dilutions
(5-fold dilutions were required for the wild-type I-CreI versus
A:T ± 4 G:C ± 10 assay). Reactions took place for 60 min
at 37 C and were terminated by placing digestions on ice,
followed by addition of loading buffer containing SDS
(to 0.5% w/v), and electrophoresis through 1.2% agarose
gels in 1X TBE buffer. The density of agarose bands was
determined using a Kodak Image Station 440CF and Kodak
1D software; the fraction of DNA cleaved was calculated
by dividing the density of product bands by the density of
substrate plus product bands. Absolute activities were
determined for each endonuclease as the amount of protein
required for 50% cleavage of a 100 ng sample of cognate
target site containing plasmid DNA: w.t I-CreI 0.3 pg,
Q44V 0.2 pg, Y33R/Q44V 0.2 pg, N30G/S32Q/Q38K
0.3 pg, N30R/S32G/Q38Y 0.3 pg, K28R 0.3 pg, N30S/
Q38R 0.5 pg, Q26C/T42E/Y66R 0.9 pg, Y33R 1.4 pg.
Crystallography
The DNA for co-crystallization was purchased from Oligos
etc. (Wilsonville, OR). For the enzyme mutant Q44V, the
DNA duplex consisted of two strands of sequences 50-GCAA-
AACGACGTGAGTCAGTTTCG-30 and its complement 30-
CGTTTTGCTGCACTCAGTCAAAGC-50 (the two altered
bases in each half site are bold and underlined). For the
Figure 1. I-CreI/DNA contacts. Direct protein/DNA hydrogen bonds are red; water molecules and water-mediated hydrogen bonds are blue. Palindromic bases
are green; non-palindromic are white. Scissile phosphate groups are indicated with black dots.
Table 1. CreI mutants analyzed in vivo
Amino acid substitution(s) Sites assayed
Q44X
a ±4 sites
b
R68X
a ±5 sites
b
K28X
a ±7 sites
c
Q26C/Y66R/T42 to R, S, Q,
C, K, N, E, H, F; Q26C/T42E
G:C ±6
T42E/Y66R WT and C:G
and T:A ±6
Q26A/T42E/Y66R, Q26A/T42E A:T ±6
N30 to A, Q, C, G; Q38 to A, E, G, R; N30A/Q38
to A, C, I, K, L, M, N, P, R, S, T; N30R/Q38A,
N30S/Q38A, N30G/Q38A, N30G/Q38Y, N30S/Q38R,
N30T/Q38R, N30C/Q38R, N30L/Q38R, N30E/Q38K,
N30S/Q38K, N30R/Q38T, N30R/S32G/Q38A,
N30R/S32G/Q38Y, N30G/S32Q/Q38A,
N30G/S32Q/Q38K, N30R/S32Q/Q38A,
N30P/S32L/Q38A
±9 sites
b
aIndicates all 19 mutants with single amino acid substitutions at that I-CreI
position.
bThe wild-type I-CreI site (WT), as well as the three symmetrically altered
mutant target sites at that position.
cThe wild-type I-CreI site, as well as the four symmetrically altered mutant
target sites at ±7.
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strands of sequences 50-GCAAATCGTCGTGAGACAATT-
TCG-30 and its complement 30-CGTTTAGCAGCACTCTG-
TTAAAGC-50. Crystals were grown for Q44V and K28R
I-CreI bound to their respective cognate DNA constructs
using a 1.5:1 molar ratio solution of DNA:protein, by hanging
drop vapor diffusion against a reservoir containing 20 mM
NaCl, 10 mM calcium chloride, 100 mM MES pH ranging
from 6.2 to 6.8 and PEG 400 ranging from 21 to 33.5%
v/v. The ﬁnal concentration of I-CreI in the protein/DNA
complex solution was 2.5 mg/ml. For both experiments, the
crystal belongs to space group P21, with unit cell dimensions
approximately a ¼ 43 s,b¼ 68 s and c ¼ 88 s (Table 2).
Crystals were removed directly from the drops in which
they grew, suspended in a ﬁber loop, frozen in liquid nitrogen
and maintained at 100 K during data collection. Data from
crystals of the Q44V/DNA and K28R/DNA complexes
were collected in house using an RAXIS-IV imagine plate
area detector (Rigaku, USA) and a rotating anode X-ray gen-
erator with a copper source providing X-rays at 1.54 A ˚ wave-
lengths. Data were reduced using the DENZO/SCALEPACK
crystallographic data reduction package (17) (Table 2).
The structures were solved via molecular replacement
using EPMR (18) with the wild-type I-CreI/DNA complex
structure as an initial search model. All structures were
modeled in XtalView (19) and reﬁned using CNS (20) with
5% of the dataset aside for cross-validation (21). The ﬁnal
reﬁnement statistics (Table 2) for Q44V were dmin ¼ 2.3 A ˚,
Rwork/Rfree ¼ 23.5/27.9 and for K28R were dmin ¼ 2.3 A ˚,
Rwork/Rfree ¼ 25.0/30.2. Geometric analysis of the structures
using PROCHECK (22) indicates no residues in any structure
with generously allowed or unfavorable backbone dihedral
angles.
RESULTS
Identification of altered specificity I-CreI derivatives
We have identiﬁed altered speciﬁcity I-CreI derivatives using
an E.coli-based genetic screen (13,14). Brieﬂy, plasmid-
encoded I-CreI alleles are introduced into cells and assayed
for the ability to cleave various target sites. These target
sites are located on F0 lac episomes, in place of lacO
sequences. Efﬁcient target site cleavage results in cells
being converted from lac
+ to lac
 , as evidenced by white
or sectored colonies on media containing the b-galactosidase
indicator X-gal (Figure 2).
I-CreI recognizes and cleaves a largely palindromic target
sequence, with 7 of 11 bases identical between half-sites. The
majority of contacts between the homodimeric enzyme and
its DNA substrate occur at these palindromic positions
(Figure 1). To ensure that each monomer in an I-CreI
homodimer is presented with the same potential contacts,
we focused on symmetrical target sequence mutations,
where each member of a symmetrical pair is altered in the
same fashion. Thus, for each palindromic position in the I-
CreI target site, three symmetrical mutant sites were
examined; for each non-palindromic position, four symmet-
rical mutant sites were examined. Site mutants that displayed
resistance to cleavage by wild-type I-CreI were used as sub-
strates to screen for novel endonucleases. Endonuclease
derivatives were chosen in which mutations were made at
amino acid position(s) predicted to interact at or near the
altered target site bases.
Residue 44 and position ±4: a specificity-shift via a
single side-chain substitution
In wild-type I-CreI, the glutamine residue at position 44
has been shown to form hydrogen bonds directly with the
adenines present at target site positions ±4 (11,12). We had
previously shown that a Q44A mutant retained some activity
towards the wild-type target site, as evidenced by sectored
colonies in our in vivo assay (13). To better understand the
interactions at this position, we created the remaining 18
I-CreI mutants encoding unique amino acids at codon 44
and screened each for activity. Like Q44A, a number of
these other mutants (Q44C, Q44I, Q44L, Q44M, Q44S,
Q44T, Q44V and Q44W) displayed some activity towards
the wild-type target site (Table 3). Each resulted in sectored
colonies in vivo, in contrast to wild-type I-CreI, which yields
white colonies. Thus, the interaction between the glutamine
present at residue 44 in wild-type I-CreI and the wild-type
T:A ±4 base pair appears to be optimal.
The three symmetrical target site mutants altering target
site positions ±4 are all I-CreI resistant in vivo. When the
19 I-CreI mutants with substitutions at codon 44 were
screened against these target sites, ﬁve endonucleases
(Q44A, Q44C, Q44T, Q44W and Q44V) with increased afﬁn-
ities for the A:T ±4 site were revealed (Table 3). Each pro-
duced sectored colonies in our in vivo system. Of these, the
Q44V mutant was deemed optimal, as it resulted in the
majority of colonies in our assay being completely white,
with a minority displaying small blue sectors (Figure 2).
No endonuclease displayed increased activity towards either
the C:G ±4 or the G:C ±4 sites.
A 6-His tagged version of the Q44V mutant was puriﬁed
and examined in cleavage competition assays as described
previously (13,14). The Q44V mutant displayed a 2.7-fold
preference for the A:T ±4 site over the wild-type site in vitro;
wild-type I-CreI displayed a 3.4-fold preference for the wild-
type site over the A:T ±4 site (Table 4 and Figure 3). Thus,
Table 2. Data processing and refinement statistics
Protein K28R Q44V
Space group P2(1) P2(1)
Cell parameters (A ˚)a ¼ 43.1 a ¼ 43.1
b ¼ 68.2 b ¼ 68.0
c ¼ 87.5 c ¼ 87.5
g ¼ 91.4 g ¼ 91.5
Resolution 2.3 s 2.3 s
Redundancy 3.3 2.2
Completeness (%)
a 96.0 (93.9) 85.4 (80.5)
Average I/s(I)
a 32.7 (14.7) 25.8 (10.3)
Rsym (%)
a 3.9 (9.7) 3.9 (9.1)
Rwork (%) 25.0 23.5
Rfree (%) 30.2 27.9
Ramachandran plot (% of modeled residues)
Most favored 87.4 87.4
Additionally allowed 12.6 12.6
Disallowed 0.0 0.0
Average B(A ˚ 2) (protein, DNA) 22.3 25.2
aOuter resolution bin 2.34–2.30.
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shift, with little speciﬁcity broadening (Table 4).
The structure of Q44V bound to its cognate target sites
clearly illustrates the structural basis behind its altered speci-
ﬁcity proﬁle. In the wild-type endonuclease complex, residue
Q44 is primarily responsible for base-speciﬁc readout of base
pairs ±4 in the DNA half-sites, by making two hydrogen-
bond contacts to an adenine base: one direct hydrogen bond
contact to its N7 nitrogen (Figure 4A), and a water-mediated
hydrogen-bond to its extracyclic amine. These contacts make
recognition of base pairs ±4 by the wild-type endonuclease
among the most speciﬁc of all positions in the protein/
DNA complex (12). In contrast, the crystal structure of
Q44V bound to its novel target demonstrates that the valine
side-chain participates in a complementary hydrophobic
packing arrangment with the thymine extracyclic methyl
group (Figure 4B). One g-carbon of the valine side-chain
forms a van der Waals contact with the thymine methyl
group (distance ¼ 3.7 A ˚) and with the d-carbon of neigh-
boring isoleucine 77 (3.6 A ˚). In addition, the second g-carbon
of V44 is packed against the d-carbon of isoleucine 24
(3.7 A ˚) and the g-carbon of threonine 42 (3.4 A ˚), completing
a hydrophobic pocket surrounding the thymine base that
comprises four separate aliphatic side-chains. Modeling of
the Q44A mutant (shown above to recognize A:T ±4, albeit
less well than Q44V) indicates that this mutation would
allow unhindered positioning of the thymine methyl group
in a hydrophobic environment, but that the packing scheme
described above would be less stable, due to the absence of
the two g-methyl groups of the valine side-chain.
Residue 68 and position ±5: recalcitrance to specificity
changes via single side-chain substitutions
In the wild-type I-CreI/DNA complex, the R68 in each
monomer forms two hydrogen bonds with the guanine present
at ±5 in each half-site (Figure 1) (11,12). We had previously
shown that an R68A mutant was inactive against a wild-type
target site (13). The remaining 18 I-CreI mutants with unique
substitutions at codon 68 were generated and screened for
activity. When examined against the wild-type target site,
only one mutant (R68K) displayed any activity, producing
sectored colonies in our assay. Thus, the wild-type arginine
at position 68 appears to be optimal for recognition of the
wild-type target site. The three symmetrical target site
mutants altering target site positions ±5 are all I-CreI resistant
in vivo (13). When the 19 I-CreI mutants with substitutions
Figure 2. In vivo endonuclease assays. Colony phenotypes resulting from transforming indicated I-CreI derivatives into cells harboring the indicated target site
mutants (13). Increased proportion of white cells within colonies indicates increased site affinity. The Q26C/Y66R mutant has been described previously (14).
Table 3. Active endonuclease derivatives identified
Target site Active I-CreI derivatives
a
A:T ±4 Q44A, Q44C, Q44T, Q44W, Q44V
A:T, C:G and T:A ±7 K28R
C:G ±9 Q38G, N30R/Q38A, N30G/Q38A, N30G/Q38Y,
N30R/Q38T, N30R/S32G/Q38A, N30R/S32G/
Q38Y
G:C ±9 N30A/Q38R, N30S/Q38R, N30T/Q38R, N30E/
Q38K, N30G/S32Q/Q38A, N30G/S32Q/Q38K
Wild-type Q44A, Q44C, Q44I, Q44L, Q44M, Q44S, Q44T,
Q44V, Q44W, R68K, K28R, N30G, N30A,
Q38G, Q38A, N30G/Q38A, N30R/S32G/Q38A
aAll novel interactions identified displayed some level of in vivo sectoring;
examples are shown in Figure 2.
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displayed activity towards any of the mutant sites.
Position ±6: enhanced site recognition via altering a
water-mediated contact
Four of eleven I-CreI target site positions are non-
palindromic between half-sites (±1, 2, 6 and 7). Bases
at two of these sites (±6 and ±7) are involved in important
interactions with I-CreI residues (Figure 1) (12). Interactions
between residues at I-CreI position 26 and bases at target
site positions ±6 have been described previously (14).
Brieﬂy, when the four mutant target sites with symmetrical
bases at ±6 were examined, the two that shared a base pair
with the native site were efﬁciently cleaved by wild-type
I-CreI, yielding completely white colonies in vivo. The two
completely novel symmetrical target sites at ±6 were
each resistant to cleavage by I-CreI. By screening I-CreI
Figure 3. Relative cleavage of cognate and non-cognate targets. Wild-type (left) and Q44V (right) endonucleases were exposed to linearized plasmids containing
wild-type and A:T ±4 homing sites. The left lanes in each gel (upper) indicate the enzyme concentration required for complete digestion of each substrate. Serial
2-fold dilutions were performed, and the relative enzyme concentrations required for 50% cleavage of each substrate determined (lower).
Table 4. Cognate versus non-cognate cleavage efficiencies
Target site I-CreI mutant Wild-type cognate: non
a Mutant cognate: non
a Specificity shift
b Specificity broadening
c
A:T ±4 Q44V 3.4 2.7 9.4 0.78
G:C ±6 Q26C/T42E/Y66R 8.0
d 2.9 23.5 0.37
T:A ±7 K28R 5.3 0.8 4.2 0.15
C:G ±9 N30R/S32G/Q38Y 2.6 3.2 8.3 1.26
G:C ±9 N30S/Q38R 2.6 2.4 6.3 0.90
G:C ±9 N30G/S32Q/Q38K 2.6 2.1 5.6 0.81
G:C ±10 Y33R 4.0
d 1.5 6.1 0.38
A:T ±4 G:C ±10 Y33R/Q44V >450 3.2 >1440 <0.007
aIndicates the ratio of enzyme concentrations yielding 50% cleavage of cognate to non-cognate target sites for the enzyme/site combination indicated. Standard
deviations were all <20%, with the exception of the wild-typeI-CreI versus A:T ±4 G:C ±10 assay which yielded values of 456,1622 and 2488; the larger variation
in this series is presumably due to the large enzyme dilutions required to achieve 50% cleavage of both wild-type and mutant sites in these assays.
bProduct of wild-type and mutant cognate to non-cognate cleavage efficiencies, as described previously (14).
cRatioofmutantcognatetonon-cognate/wild-typecognatetonon-cognatecleavageefficiencies,asdescribedpreviously(14).Valuesgreaterthan1indicatehigher
specificity, while values of less than 1 indicate broader specificity.
dFrom (14).
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afﬁnities for each of these mutant sites were revealed: a
Q26A mutant displayed optimal activity towards the A:T
±6 site while a Q26C mutant displayed optimal activity
towards the G:C ±6 site (14).
Water-mediated contacts between endonuclease and target
DNA are also important at this site (Figure 1) (12). In the
native complex, water bridges occur between bases at this
position and I-CreI residues T42 and Y66. We have
previously described a Y66 to R substitution that increased
the activity of the Q26C mutant towards the G:C ±6 site
(14). We have followed up on that result by examining the
effect of changes at I-CreI residue 42. A total of 9 amino
acid substitutions (to R, S, Q, C, K, N, E, H, F) at this
position were examined. Each was combined with the
Q26C and Y66R substitutions, and screened for the ability
to improve recognition of the G:C ±6 site mutant. One subs-
titution, 42E, resulted in enhanced site recognition (Figure 2).
The Q26C/T42E/Y66R triple mutant displayed a 2.9-fold
preference for its cognate site in vitro (Table 4), up from
2.4-fold for the Q26C/Y66R double mutant (14).
We next examined effects of the T42E substitution in
different contexts in our in vivo system. The T42E/Y66R
combination alone decreased the activity of otherwise
wild-type I-CreI (Q26) towards the wild-type target site, as
well as for the two palindromic sites that feature a wild-
type contact (C:G ±6 and T:A ±6, Figure 1). Interestingly,
we found that the activity of Q26A towards the A:T ±6 site
was improved slightly by the addition of the T42E/Y66R
combination. We had shown previously that the Y66R muta-
tion alone decreased the activity of Q26A towards the A:T
±6 site (14). Similarly, the T42E substitution added alone
to Q26A or Q26C decreased recognition for cognate target
sites. Thus, it appears that the T42 to E and Y66 to R substi-
tutions must be present together for optimal recognition of
the G:C ±6 site by Q26A, and of the A:T ±6 site by Q26C.
Figure 4. Structures and interactions of cognate pairs at residue 44 and base pair ±4 and residue 28 and base pair ±7. Protein/DNA contacts between wild-type I-
CreI and its binding site are shown in (A and C). Contacts between Q44V and K28R and their cognate sites are shown in (B and D), respectively. The sequences
of wild-type I-CreI target sequence and the alternate target sequences are shown below their corresponding structures. Dashed green lines represent hydrogen
bonding and dashed magenta lines represent van der Waals interactions.
4796 Nucleic Acids Research, 2006, Vol. 34, No. 17For target sites with other bases at ±6, the T42E/Y66R
combination results in decreased recognition.
Residue 28 and position ±7: a specificity-broadening
substitution
Target site position ±7 is non-palindromic, with I-CreI
residue K28 hydrogen bonding with a thymine in one half-
site and a guanine in the other (Figure 1) (11,12). As was
the case at position ±6 (14), the two symmetrical mutant
target sites that share a base pair with the native site (A:T
±7 and C:G ±7) were efﬁciently cleaved by wild-type
I-CreI, yielding completely white colonies in vivo. The two
completely novel symmetrical target sites at ±7 were each
resistant to cleavage by I-CreI, as demonstrated by blue
colonies.
Each of 19 amino acid substitutions altering position
28 were generated and assayed against the wild-type target
site and the four mutant sites symmetrically altered at bases
±7. The only active endonuclease was the K28R mutant.
Like wild-type I-CreI, the K28R mutant recognizes the native
site (Figure 2) and each symmetric homing site containing a
native base pair. When assayed against these three sites, the
K28R mutant yielded mostly white colonies with small blue
sectors, indicating a slightly lower afﬁnity than wild-type
I-CreI for these three sites. However, unlike wild-type
I-CreI, the K28R mutant was also active against one of the
two completely novel sites, T:A ±7 (Table 3), yielding
sectored colonies in vivo (Figure 2). The similar afﬁnity of
K28R for both the wild-type and the T:A ±7 sites in vivo
was conﬁrmed in vitro, where the K28R mutant displayed a
slight 1.2-fold preference for the wild-type site (Table 4).
In contrast, wild-type I-CreI displayed a 5.3-fold preference
for the wild-type site over the T:A ±7 site. Thus, the K28
to R substitution results in signiﬁcant speciﬁcity broadening
(Table 4), enabling the enzyme to recognize a completely
novel site while maintaining relatively high activity towards
the wild-type site.
The structure of K28R bound to the T:A ±7 site demon-
strates the basis of that mutant’s broadened speciﬁcity. The
introduction of an additional guanidino nitrogen moiety at
the end of the arginine side-chain expands the conformational
and hydrogen-bond repertoire of that side-chain. In this case,
the new side-chain makes a water-mediated contact from its
NH2 side-chain nitrogen to the N7 nitrogen of the adenine
base in the new T:A base pair, while still allowing a similar
contact to the N7 nitrogen of guanine in the wild-type target
site (Figure 4C and 4D).
Position ±9: multiple substitutions required for optimal
site recognition
The I-CreI/DNA contacts at target site bases ±9 are unique in
that bases on each strand of DNA participate in direct hydro-
gen bonding with endonuclease residues: Q38 in each mono-
mer forms two hydrogen bonds with the adenine present in
each half-site, while N30 in each monomer forms a single
hydrogen bond with each thymine on the opposite strand
(Figure 1) (11,12). We had previously shown that an N30A
mutant retained activity towards the wild-type target site, as
evidenced by sectored colonies in our in vivo assay (13).
Here, we began by screening mutants altered at residue
38 for novel contacts. To minimize the potential for unfavor-
able interactions between N30 and corresponding mutant
bases, these studies were done in the presence of the N30
to A substitution. Eleven codon 38 substitutions were isolated
in this context (to A, C, I, K, L, M, N, P, R, S and T). Each
was assayed in vivo against the wild-type site and the three
symmetrical sites altered at ±9 (Table 1). Of these, only the
N30A/Q38R mutant displayed any activity, yielding
sectored colonies when assayed against the G:C ±9 site
(Table 3). When a Q38R single mutant (containing the
wild-type N at residue 30) was assayed against the G:C
±9 site no activity was observed, validating our approach
of screening for novel contacts at residue 38 in an N30A
background.
Having demonstrated that simultaneously altering residues
30 and 38 could result in increased activity towards a site
mutant altered at ±9, we next employed mutagenic strategies
to simultaneously alter both residues. Resulting mutants were
isolated in screens for white or sectored colonies in the F0
o-cre assay (13) in site strains altered at ±9 (Figure 1).
These efforts yielded an additional eleven mutants altering
residues 30 and 38 (Table 1). Of these, four displayed
activity against the C:G ±9 site, and three displayed activity
against the G:C ±9 site (Table 3).
Crystallographic analysis of wild-type and mutant
I-CreI/DNA complexes revealed a hydrogen bond pair
between N30 and the adjacent S32 (14). Reasoning that
substitutions at residue 30 may be constrained by S32, we
isolated mutants in which I-CreI residues 30, 32 and
38 were simultaneously altered. These efforts yielded two
more novel endonucleases that target the C:G ±9 site, as
well as two that target the G:C ±9 site (Table 3). In total,
36 single, double and triple mutants altering residues 30, 32
and 38 were analyzed in this study (Table 1). Seven mutants
with increased activities towards the C:G ±9 site and six with
increased activities towards the G:C ±9 site were identiﬁed
(Table 3). None of our mutants displayed increased activity
towards the T:A ±9 site.
Based upon in vivo phenotypes, we concluded that the
N30R/S32G/Q38Y mutant had the highest activity towards
the C:G ±9 site, and that the N30S/Q38R and N30G/S32Q/
Q38K mutants had the highest activities towards the G:C
±9 target site (Figure 2). These three mutants were puriﬁed
and examined in vitro. Each displayed a 2- to 3-fold prefer-
ence for the cognate mutant site. As wild-type I-CreI shows
a similar preference for its cognate site, the total speciﬁcity
shifts displayed by these mutants were 5- to 8-fold (Table 4).
An engineered endonuclease resulting from combining
novel contacts
We have previously described an I-CreI Y33R mutation
that results in high afﬁnity for a G:C ±10 site mutant (13).
To test whether novel contacts can be mixed and matched
to generate I-CreI derivatives with predicted speciﬁcities,
we engineered an endonuclease containing both the Y33 to
R and Q44 to V substitutions. The Y33R/Q44V mutant was
assayed in vitro against the corresponding target site con-
taining two mutations in each half-site (A:T ±4 and G:C
±10). The mutant displayed a >1440-fold speciﬁcity shift,
more than an order of magnitude greater than the product
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be noted that the majority of this shift resulted from wild-
type I-CreI displaying such a low afﬁnity for the mutant
target site. The Y33R/Q44V endonuclease has undergone
signiﬁcant speciﬁcity broadening (Table 4), an undesired
result in the quest to create highly speciﬁc engineered
endonucleases.
DISCUSSION
Engineered homing endonucleases hold great promise for a
variety of applications, from gene therapy in humans to the
eradication of natural populations of pathogens (23). Our
work and that of others has clearly established I-CreI as the
most extensively characterized, and the most widely engi-
neered, homing endonuclease (5,13–15,24,25,26). The work
described above signiﬁcantly extends our ability to engineer
novel I-CreI derivatives and provides important insights
into the mechanisms by which homing endonucleases have
evolved.
Structural studies have identiﬁed speciﬁc protein/DNA
contacts at 8 of 11 bp in each half-site of the I-CreI target
sequence (Figure 1). Our previous studies have described
single amino acid substitutions resulting in novel interactions
at three of these eight positions: ±10 and ±11 (13), and
±6 (14). Here we described novel interactions resulting
from single amino acid substitutions at two other positions,
±4 and ±7. We also demonstrated that no single amino acid
substitutions altering residue 68 yielded novel interactions
with site mutants altered at positions ±5. The R68K
mutant did, however, retain signiﬁcant activity toward the
wild-type target site, illustrating the importance of a
basic residue at this position. Interestingly, novel I-CreI
derivatives with arginine altered to non-basic residues at
amino acid 68 have been described by others, all in the
context of endonucleases containing a D75N mutation (15).
Taken together, these results support the existence of a
structurally predicted salt-bridge between R68 and D75 in
wild-type I-CreI (12).
Given that the direct I-CreI/DNA contacts in the native
complex involve exclusively polar amino acids (Figure 1)
(11,12), it may come as a surprise that four hydrophobic sub-
stitutions (to A, C, W and V) were recovered that improved
recognition of the A:T ±4 site, with the Q44 to V substitution
being optimal. However, this is the third I-CreI position we
have described in which substitutions to less polar residues
impart speciﬁc recognition of target-site thymines; Y33C at
T:A ±10 and Q26A at A:T ±6 are the others (13,14). Here
and in the case of Y33C (14), the co-crystal structures
revealed van der Waals contacts to the C5 methyl group of
the thymine. The crystal structure of the homing endonuc-
lease I-CeuI revealed a similar van der Waals interaction
with thymine, in this case involving a leucine residue (27).
The ability of such a wide-range of amino acids to direct
speciﬁc DNA recognition towards thymines illustrates the
importance of considering multiple amino acid substitutions
when attempting to engineer homing endonucleases to target
novel DNA sequences.
The interaction at the asymmetric target position ±7
involves direct hydrogen bonding of K28 to a thymine in
one half-site and a guanine in the other. The importance of
contacts at this position is established by the fact that both
completely novel symmetric mutant sites are resistant to
I-CreI cleavage in vivo. Since efﬁcient cleavage of each
symmetrical site that shares a base pair with the native site
was observed, we conclude that each interaction in the native
complex contributes to DNA recognition. The K28R mutant
has undergone ‘speciﬁcity broadening’ in that it retains
high afﬁnity for the wild-type site and gains the ability to
efﬁciently cleave one of the two completely novel mutant
sites. The S32K mutant we have described previously (13)
has similar properties. Relaxed speciﬁcity mutants, such as
K28R and S32K may be important evolutionary interme-
diates, enabling an enzyme to recognize its native target
site as well as one or more closely related sites.
The interaction at target site position ±9 is the only one
involving direct hydrogen bonding to bases on each DNA
strand (Figure 1). Given this fact, it is not surprising that
multiple amino acid substitutions are required for optimal
recognition. What is surprising is the relatively modest
speciﬁcity shifts displayed by the three mutants we have
characterized (Table 4). Each of these is lower than that of
the single Q44V mutant. One possible explanation for this
result is that the interaction at position ±4 is more important
for DNA recognition than that at ±9, a notion supported
by information content calculations (12,28). Another expla-
nation is that the mutants isolated thus far that target novel
±9 sequences are sub-optimal, a very real possibility given
the non-saturating nature of our screens for these mutants.
However, even with our limited sampling, we can infer
some rules for homing endonuclease site recognition. For
example, ﬁve of the six endonucleases we have identiﬁed
that target G:C ±9 have basic residues at amino acid 38,
positioned to interact with the top-strand guanine. This ﬁts
with three other examples of basic residues recognizing
guanines in the native structure (R70, R68, K28; Figure 1).
Further, the I-CreI homolog I-MsoI recognizes a target site
containing a top-strand guanine at position -9 via direct
hydrogen bonding with an arginine residue (12).
The structures of Q44V and K28R I-CreI bound to their
novel cognate target sites clearly illustrate the structural
basis behind their altered speciﬁcity proﬁles, and the extent
to which individual contacts between enzyme side-chains
and nucleotide bases can be independently modiﬁed. As
was the case with the previously described Y33C and
Y33H structures (14), selection of a single residue substitu-
tion results in a unique alteration of contacts to an individual
base, with little perturbation of neighboring side-chain con-
formations and contacts. Thus, modular redesign strategies
of homing endonuclease speciﬁcity are supported by the
structural data.
The step-wise approach we have employed, involving the
use of saturation mutagenesis at individual protein/DNA
contact positions and subsequently combining novel contacts,
is one way to create novel homing endonucleases with altered
target speciﬁcities. Others have reported selection schemes
and high-throughput approaches to achieve this goal (15,26,
29,30). The most successful of these, in terms of the number
of novel endonucleases identiﬁed, was a yeast-based system
used to isolate I-CreI derivatives simultaneously altered at
residues 44, 68 and 70 (15). Even such high-throughput
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required when attempting a saturation screen involving
multiple amino acid positions. For example, we have shown
here that Q44V is optimal for interaction with a bottom strand
thymine at ±4. Arnould et al. (31) did not identify this
substitution among their vast set of mutants altered at residue
44, presumably because their mutagenesis focused on only
12 of the 20 amino acids, and valine was excluded from
that set. Recent work suggests that computational protein
redesign will emerge as a powerful complement to genetic
approaches for engineering homing endonucleases with
novel target speciﬁcities. The engineering of highly speciﬁc
endonucleases tailored to speciﬁc DNA targets of interest
may ultimately involve a combination of these different
approaches.
Unlike the engineering of endonucleases, the evolution of
homing endonucleases undoubtedly involved sequential
random mutations resulting in changes in target speciﬁcity.
We have demonstrated that single amino acid substitutions
can result in new endonucleases that target novel sites
with speciﬁcities similar to that displayed by wild-type
(i.e. Q44V), and can also result in new endonucleases with
broader speciﬁcities (i.e. K28R). After movement into a
new host, such broad speciﬁcity endonucleases may impart
toxicity due to afﬁnity for multiple targets, and thus undergo
selective pressure to be made more speciﬁc by further
mutation. These subsequent mutations could involve altering
residues that participate in direct protein/DNA contacts or
those that interact with DNA via water-mediated contacts
(i.e. T42E). Even in cases where multiple residues participate
in the recognition of a single base pair, a single amino acid
substitution can retain afﬁnity for the native site while provi-
ding a substrate for further productive mutations: the N30G,
N30A, Q38G and Q38A mutants all retain partial recognition
of the wild-type target site, and when paired with second (and
sometimes third) mutations enable the speciﬁc recognition of
mutant sites (Table 3). The step-wise analysis of single pro-
tein DNA contacts we have described thus provides important
insights into the evolution of novel target speciﬁcities by
homing endonucleases.
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